Aspen Technology Statistics

Total Valuation

Amniotics AB has a market cap or net worth of SEK 14.76 million. The enterprise value is 14.60 million.

Market Cap	14.76M
Enterprise Value	14.60M

Important Dates

The last earnings date was Tuesday, February 18, 2025.

Earnings Date	Feb 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Amniotics AB has 2.73 billion shares outstanding. The number of shares has increased by 9,149.92% in one year.

Current Share Class	n/a
Shares Outstanding	2.73B
Shares Change (YoY)	+9,149.92%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	24.27%
Owned by Institutions (%)	5.64%
Float	1.78B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.11
PB Ratio	1.83
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.72
EV / Sales	5.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.74

Financial Position

The company has a current ratio of 0.41

Current Ratio	0.41
Quick Ratio	0.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.59

Financial Efficiency

Return on equity (ROE) is -236.31% and return on invested capital (ROIC) is -137.51%.

Return on Equity (ROE)	-236.31%
Return on Assets (ROA)	-53.67%
Return on Invested Capital (ROIC)	-137.51%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	612,500
Profits Per Employee	-5.05M
Employee Count	6
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.00% in the last 52 weeks. The beta is 0.53, so Amniotics AB's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-88.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	57.97
Average Volume (20 Days)	2,395,968

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Amniotics AB had revenue of SEK 2.45 million and -20.19 million in losses. Loss per share was -0.00.

Revenue	2.45M
Gross Profit	2.45M
Operating Income	-18.80M
Pretax Income	-20.19M
Net Income	-20.19M
EBITDA	-16.89M
EBIT	-18.80M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	156,000
Total Debt	n/a
Net Cash	156,000
Net Cash Per Share	0.00
Equity (Book Value)	8.06M
Book Value Per Share	0.00
Working Capital	-5.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.68 million and capital expenditures -58,000, giving a free cash flow of -19.74 million.

Operating Cash Flow	-19.68M
Capital Expenditures	-58,000
Free Cash Flow	-19.74M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-767.22%
Pretax Margin	-824.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-805.67%

Dividends & Yields

Amniotics AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9,149.92%
Shareholder Yield	-9,149.92%
Earnings Yield	-90.48%
FCF Yield	-133.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amniotics AB has an Altman Z-Score of -10.9. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.9
Piotroski F-Score	n/a